AMED(Delisted)
Amedisys·NASDAQ
--
--(--)
Signals Analysis
Bullish signal 1
Bearish signal 1
Revenue Beats Expectation
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About AMED
Amedisys, Inc.
A leading provider of quality home health, hospice, personal care and high-acuity care
3854 American Way, Suite A, Baton Rouge, LA 70816
--
Amedisys, Inc., originally incorporated in Louisiana in 1982, was founded by William F. Borne. William F. Borne is also the Chief Executive Officer and President of the Company's Board of Directors. The company later transferred its business to a Delaware corporation, which was incorporated in 1994 and became a publicly traded company in August of the same year. Amedisys is an industry-leading health care company dedicated to bringing meticulous care to the home. The company brings personalized health care services to patients and their families, providing approximately 11.1 million return visits to patients' homes each year. The company's goal is to help lead the new patient-centered service revolution through top-level, innovative home health care. This means rethinking how the United States views health problems caused by aging.
Company Financials
EPS
AMED has released its 2025 Q2 earnings. EPS was reported at 1.54, versus the expected 1.33, beating expectations. The chart below visualizes how AMED has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
AMED has released its 2025 Q2 earnings report, with revenue of 621.86M, reflecting a YoY change of 5.19%, and net profit of 29.05M, showing a YoY change of -10.81%. The Sankey diagram below clearly presents AMED's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
Related Symbols
You can ask Aime
No Data
